WHO Experts Welcome Oxford COVID-19 Vaccine

(Department of Public Information) The World Health Organisation (WHO) on Monday, welcomed new findings from Oxford University researchers on a novel coronavirus (COVID-19) vaccine, which triggered an immune response.

However, the organisation noted the findings are still early.

A team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group https://t.co/NZn1ReQ0gb has taken the next step towards the discovery of a safe, effective and accessible vaccine against #coronavirus. #COVIDー19 #CoronavirusVaccine

— Caribbean Community (CARICOM) (@CARICOMorg) July 22, 2020

“In generating T-cell responses and generating neutralising antibodies, this is a positive result. But again, there is a long way to go. We now need to move into larger-scale real-world trials,” Dr. Michael Ryan, Executive Director of the WHO’s Health Emergencies Programme, said.

The vaccine, called ChAdOx1 nCoV-19, was tested in 1,077 participants and was said to have produced antibodies and killer T-cells in 90 percent of participants to combat COVID-19.

“It is good news” and that trials must now be expanded to a broader sample size to better test its effectiveness,” Dr. Ryan stated.

Read more at: Department of Public Information